In this cohort, we found significantly higher levels of caspase‐3 activation in TREM2 AD synaptosomes compared with NDC and similarly when comparing synaptosomes derived from patients without pathology, between TREM2 NDC and NDC (Fig 4G and H). This evidence concerns the gene TREM2 and Alzheimer disease.